MwanzoONC • TSE
add
Oncolytics Biotech Inc
Bei iliyotangulia
$ 0.45
Bei za siku
$ 0.45 - $ 0.50
Bei za mwaka
$ 0.45 - $ 2.08
Thamani ya kampuni katika soko
43.52M CAD
Wastani wa hisa zilizouzwa
elfu 125.25
Uwiano wa bei na mapato
-
Mgao wa faida
-
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CAD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 7.00M | -19.79% |
Mapato halisi | -6.69M | 3.00% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.08 | 11.11% |
EBITDA | -6.97M | 19.83% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CAD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.30M | -48.31% |
Jumla ya mali | 19.70M | -43.30% |
Jumla ya dhima | 13.21M | 12.11% |
Jumla ya hisa | 6.49M | — |
hisa zilizosalia | 88.82M | — |
Uwiano wa bei na thamani | 5.62 | — |
Faida inayotokana na mali | -87.73% | — |
Faida inayotokana mtaji | -240.66% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CAD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -6.69M | 3.00% |
Pesa kutokana na shughuli | -6.50M | 13.00% |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | 5.89M | 293.98% |
Mabadiliko halisi ya pesa taslimu | elfu -639.00 | 87.96% |
Mtiririko huru wa pesa | -4.25M | 22.67% |
Kuhusu
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Ilianzishwa
1998
Makao Makuu
Tovuti
Wafanyakazi
28
